made the necessary changes and we hope contributions to our members and the
to continue with this report in 2009. greater biopharmaceutical community.
Corporate Sponsorship
Last, I would like to thank all the We can sponsor or cosponsor several
Program
Biopharmaceutical Section executive professional meetings throughout the
Again this year, the
members for their support, without year, including JSM and the FDA/
Biopharmaceutical Section
which none of the above could have
Industry Workshop. We are also able
is indebted to our corporate
been accomplished. I would also like to
to provide cash awards for the student
sponsors for their generous
thank all the section members for pro-
paper awards program and best contrib-
support of our ongoing programs
viding me the opportunity to serve.
uted paper program at the annual Joint
Statistical Meetings.
and activities. This year, we
A Note from Chair Invitations to become corporate spon-
have 19 corporate sponsors:
Anna Nevius
sors are mailed in January. Any compa-
Allergan, Inc. I would like to thank all the
ny interested in becoming a corporate
Biopharmaceutical Section members for
sponsor can contact me at anna.nevius@
Johnson & Johnson
giving me the opportunity to serve as
fda.hhs.gov or the chair of the Corporate
chair of your section. I especially want to
Sponsorship Committee, Russ Helms, at
AstraZeneca
thank Kannan Natarajan for the help he
Russ_Helms@RhoWorld.com. ■
Merck & Co., Inc.
has given me in moving from chair-elect
to chair. As you can see from the report
Biogen - Idec above, the section did some amazing
things last year and has plans for great
Pfizer Inc.
things this year. With your help, I am
Biometrics
Bureau of Economic Analysis
sure we can accomplish the goals listed
above and more. Please let me and the
Write for
Rho, Inc.
members of the executive committee
know about ideas you have that would
Centocor, Inc.
benefit you and the section. You can CHANCE
find the members of the executive com-
sanofi-aventis
mittee and their contact information at
Edited by Page Moore,
Cytel Inc.
www.amstat.org/sections/sbiop.
Biometrics Section Publications Officer
As Natarajan mentioned, we hope to
SAS Institute Inc. publish an issue of the Biopharmaceutical As you may know, the ASA’s CHANCE
Section Report soon. If you have topics
magazine features a regular column
Eli Lilly and Company
you would like discussed or have an
called “Here’s to your Health.” The
Schering-Plough Corporation
article you would like published, please
column publishes interesting statisti-
send them to editors Jose Alvir at Jose.
cal issues related to health presented at
GlaxoSmithKline
Alvir@pfizer.com and David H. Henry at
a basic level. Researchers are constantly
David.Henry@bms.com.
asked to write short articles for the col-
Takeda Pharmaceutical Company
The planning meeting for the 2009
umn, and now we would like to invite
FDA/Industry Workshop—to be held
you to write one. To provide a flavor
Limited Hoffmann-La Roche, Inc
September 23–25 at the Capitol Hilton
of the types of articles published recent-
Waban Software
in Washington, DC—was held Friday,
ly, here are some column topics:
January 30. The meeting was packed with
Wyeth Consumer Healthcare excited planners led by cochairs Tammy
—Statistics issues in pharmacogenetics
Massie of the FDA and Carmen Mak of
—A re-examination of the 1918 flu
Schering-Plough. At the end of the day,
pandemic
the planners returned home with excel-
lent ideas for sessions and short courses. —Application of PET scanning to
the 2008 FDA/Industry Workshop was
Stay tuned for program updates. diagnosing mental illness
a resounding success yet again. The Biopharmaceutical Section, with
Unfortunately, there were also a few more than 2,000 members, is one of the If you would like more informa-
disappointments in 2008. Due to the largest and most active sections within tion or are interested in writing for the
lack of coordination among editors, there the ASA. Thanks in large part to the help column, email Here’s to Your Health
were no Biopharmaceutical Section Reports and support of our corporate sponsors, column editor Mark Glickman at
issued. The executive committee has we can provide unique and substantial
mg@bu.edu. ■
MARCH 2009 AMSTAT NEWS 59
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40 |
Page 41 |
Page 42 |
Page 43 |
Page 44 |
Page 45 |
Page 46 |
Page 47 |
Page 48 |
Page 49 |
Page 50 |
Page 51 |
Page 52 |
Page 53 |
Page 54 |
Page 55 |
Page 56 |
Page 57 |
Page 58 |
Page 59 |
Page 60 |
Page 61 |
Page 62 |
Page 63 |
Page 64 |
Page 65 |
Page 66 |
Page 67 |
Page 68 |
Page 69 |
Page 70 |
Page 71 |
Page 72 |
Page 73 |
Page 74 |
Page 75 |
Page 76 |
Page 77 |
Page 78 |
Page 79 |
Page 80 |
Page 81 |
Page 82 |
Page 83 |
Page 84 |
Page 85 |
Page 86 |
Page 87 |
Page 88 |
Page 89 |
Page 90 |
Page 91 |
Page 92